Private Equity

Record profits from gold giants are breathing new life into once-dormant assets, but a closer look reveals a world of opportunity fraught with speculation.

Private equity firm Thurston Group launches Sensorium Clinical Research, a new network aiming to unify top trial sites and streamline medical innovation.

The luggage giant reports a 4.1% revenue increase and a major cash flow turnaround, while advancing plans for a strategic US stock market debut this year.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

A new alliance aims to develop first-in-class drugs for Alzheimer's and Parkinson's by targeting chronic brain inflammation, a key driver of disease.

Using subatomic particles from deep space, Power Metallic aims to unlock a new frontier of mineral wealth deep beneath its Quebec polymetallic project.

The uranium giant posts a net profit after its major acquisition, but a significant cash outflow has investors weighing long-term growth against short-term risks.

The nation's largest EMS provider, GMR Solutions, saw its stock surge on its NYSE debut after a major IPO price cut to appease wary investors.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

JBS posts a $221M profit despite a major loss in its US beef unit, showcasing the power of its diversified global strategy in volatile markets.

Vistage expands its global CEO advisory dominance by acquiring its longtime Canadian licensee, TEC Canada, integrating 1,600 members into its network.

Palladium Equity Partners acquires a majority stake in DME Express, signaling a major push for growth in the critical, yet scrutinized, hospice care market.

A new strategic alliance brings European cGMP-grade vitamin APIs to the U.S., promising to enhance quality and supply reliability for compounding pharmacies.

Lightpath is building a 392-mile fiber network linking two of the world's fastest-growing data hubs, a major bet on the future of AI infrastructure.

From nano-surfactants to pharmaceuticals, SureNano Science is betting its future on a novel obesity drug. Can this microcap survive the big leagues?

America's only beekeeper-owned co-op partners with a top PR firm to meet consumer demand for authenticity and amplify its century-old American legacy.

Backed by private equity, Party Reflections' latest acquisition consolidates the Charlotte event rental scene, signaling a major strategic power play.

S2G Investments launches a $1B fund to scale growth-stage firms in food, energy, and oceans, bridging a critical financing gap for market-ready solutions.

USMNT's Tyler Adams and Scotts expand their 'Keep It Real' initiative, investing in natural grass fields amid a heated debate over player safety.

CRŪ Winery's sponsorship of the California Honey Festival highlights a growing trend of eco-conscious marketing and the vital link between bees and wine.